Stock market update: Nifty Pharma index falls 0.79% in an upbeat market

NEW DELHI:  The Nifty Pharma index traded negative around 10:19AM(IST)on Tuesday in an upbeat market.

Abbott India Ltd.(up 0.74 per cent), Gland Pharma Ltd.(up 0.68 per cent), Biocon Ltd.(up 0.41 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 0.03 per cent) were among the top gainers.

Dr. Reddy’s Laboratories Ltd.(down 3.1 per cent), Ipca Laboratories Ltd.(down 2.58 per cent), Aurobindo Pharma Ltd.(down 2.0 per cent), Ajanta Pharma Ltd.(down 1.87 per cent) and Granules India Ltd.(down 1.86 per cent) were the top losers on the index.

The Nifty Pharma index was down 0.79 per cent at 21599.05 at the time of writing this report.

Benchmark NSE Nifty50 index was up 147.66 points at 23806.0, while the BSE Sensex was up 552.08 points at 78536.46.

Among the 50 stocks in the Nifty index, 35 were trading in the green, while 15 were in the red.

Shares of Vodafone Idea, IREDA, YES Bank, Suzlon Energy and Ola Electric Mobilit were among the most traded shares on the NSE.

Shares of Cura Tech, Mahamaya Steel, Jupiter Life Line Hospitals, Bohra Industries and SBI Card hit their fresh 52-week highs in today’s trade, while Shrem InvIT, Sanco Industries, AGS Transact Tech, Marshall Machines and Praxis Home Retail hit fresh 52-week lows in trade.

Related Posts

  • Pharma
  • March 29, 2025
  • 52 views
Trump to announce pharma tariffs soon

U.S. President Donald Trump said on Friday that he would soon announce tariffs targeting the pharmaceutical industry but did not provide details on timing or rates. Speaking to reporters aboard…

  • Pharma
  • March 29, 2025
  • 88 views
Traws Pharma announces CEO retirement and interim successor

NEWTOWN, Pa. – Traws Pharma, Inc. (NASDAQ: TRAW), a biopharmaceutical company focusing on antiviral therapies, has announced the retirement of its CEO, Werner Cautreels, PhD, effective at the close of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump to announce pharma tariffs soon

Trump to announce pharma tariffs soon

Traws Pharma announces CEO retirement and interim successor

Traws Pharma announces CEO retirement and interim successor

Mankind Pharma faces Rs 183 crore tax demand, plans to appeal

Mankind Pharma faces Rs 183 crore tax demand, plans to appeal

Indian Pharma Poised To Gain As US Tariffs Impact Global Rivals: JP Morgan Report

Indian Pharma Poised To Gain As US Tariffs Impact Global Rivals: JP Morgan Report